• CD20 (PTR1337/065) mouse mAb
1 1

Upingbio

YP-Ab-18164-53UL

CD20 (PTR1337/065) mouse mAb

CD20 (PTR1337/065) mouse mAb

$0.00 USD
$0.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
  • Reaction species: Human;Mouse;Rat;
  • Gene Name: MS4A1 CD20
  • Protein name: CD20
  • Molecular weight (DA): 33kD
  • Immunogen: Synthesized peptide derived from human CD20 AA range: 200-297
  • Specificity: This antibody detects endogenous levels of CD20.
  • Composition: PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
  • Source: Mouse, Monoclonal/IgG1, kappa
  • Dilution ratio: IHC 1:200-1000. IF 1:100-500. ELISA 1:1000-5000
  • Purification process: Protein G
  • Concentration: mg/ml
  • Storage: -15°C to -25°C/1 year(Do not lower than -25°C)
  • Other Names: B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1;Bp35;Leukocyte surface antigen Leu-16;Membrane-spanning 4-domains subfamily A member 1;CD antigen CD20)
  • Background: This gene encodes a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. This gene encodes a B-lymphocyte surface molecule which plays a role in the development and differentiation of B-cells into plasma cells. This family member is localized to 11q12, among a cluster of family members. Alternative splicing of this gene results in two transcript variants which encode the same protein. [provided by RefSeq, Jul 2008],
  • Function: caution:Epitope 1, mapped in PubMed:16785532, is predicted to be buried in the membrane. Its accessibility to the extracellular space, and thus to antibody recognition, is not explained.,function:This protein may be involved in the regulation of B-cell activation and proliferation.,online information:CD20 entry,pharmaceutical:Monoclonal antibodies(mAb) against CD20 are used to treat B-cell non-Hodgkin's lymphoma (NHL). These antibodies include Rituximab (Mabthera), Britumomab (Zevalin) and Tositumomab (Bexxar). CD20 engaged by mAb can generate transmembrane signals capable of directly controlling cell growth and triggering cell death in certain tumors. Alternatively, mAb
View full details